MedPath

Post-TRaUmatic STress Disorder Induced by Gynecological Brachytherapy

Not yet recruiting
Conditions
Uterine Cervical Neoplasms
Registration Number
NCT07204535
Lead Sponsor
Centre Paul Strauss
Brief Summary

This is a multicenter, prospective study aimed at providing information on the psychological effects (including post-traumatic stress symptoms) of utero-vaginal brachytherapy in patients with cervical cancer using self-administered questionnaires. The study also aims to assess the persistence of these symptoms over time, up to 5 years after brachytherapy. The results could help identify patients at risk of post-traumatic stress in this context and develop appropriate psychological interventions to improve their psychological well-being during and after treatment.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Female
Target Recruitment
80
Inclusion Criteria
  • Confirmed diagnosis of cervical cancer with an indication for High-dose rate (HDR) or pulse-dose rate (PDR) uterovaginal brachytherapy;
  • Squamous cell carcinoma or other histological types;
  • WHO ≤ 2;
  • Ability to complete validated questionnaires in French;
  • Informed consent to participate in the study;
  • Patients over 18 years old
Exclusion Criteria
  • Inability to understand or respond to questionnaires due to a cognitive disorder, intellectual disability, language barrier, or psychiatric disorder that impairs judgment;
  • Patient under juridic protection;
  • Pregnant or breastfeeding woman

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Post-Traumatic Stress Disorder evaluationat 2 months

Evaluation with post-traumatic stress disorder Checklist version DSM-5 (PCL-5) - questionnaire with a Cut off score ≥ 32

Secondary Outcome Measures
NameTimeMethod
Anxiety and Depressionuntil 60 months

Hospital Anxiety and Depression scale

Quality of Life (general module)until 60 months

Evaluated with EORTC QLQ-C30 questionnaire

Quality of Life (cervical cancer module)until 60 months

Evaluated with EORTC QLQ-CX24 questionnaire

Sexual Health evaluationuntil 60 months

Sexual Health Questionnaire (EORTC SHQ-22)

Trial Locations

Locations (1)

ICANS

🇫🇷

Strasbourg, France

ICANS
🇫🇷Strasbourg, France
George NOEL, MD, PhD
Contact
368766767
promotion-rc@icans.eu

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.